Oxidative stress, indicated by skin Advanced Glycation End products, and tobacco smoking in relation to psychotic experiences and cognitive symptoms
Oxidative stress and inflammation are thought to underly the development of psychotic disorders
(also called schizophrenia-spectrum disorders [SSD]) (Fraguas et al., 2018). Oxidative stress implies
an imbalance between reactive oxygen species and antioxidants (redox dysregulation). Depletion of
glutathione, an important antioxidant in the brain, due to high levels of oxidative stress or
inadequate synthesis of glutathione are thought to cause decreased activity of the NMDA-receptor in
the medial prefrontal cortex. This results in dysregulation of the dopaminergic system which in turn
can cause psychotic symptoms (Perkins et al., 2020). Thus far, an association of redox dysregulation
and severity of negative symptoms (i.e. diminished emotional expression or avolition) has been
found (Matsuzawa et al., 2008). No other clinical parameter has been found to be associated with
(peripheral) biomarkers indicating oxidative stress in patients suffering from SSD (Flatow et al.,
2013).
Advanced Glycation End products (AGEs) are oxidated and glycated proteins and lipids that play a
role in the cascade linking oxidative stress and neuroinflammation (Perkins et al., 2020). Skin
autofluorescence (SAF) measures of AGEs serve as indicator of cumulative oxidative stress and
increased levels have been demonstrated in individuals suffering from SSD (Hagen et al., 2017;
Kouidrat et al., 2013), as well as in those suffering from affective disorders (Hagen et al., 2020)
compared to a healthy control group. Investigation of the association between SAF and self-reported
psychotic symptoms in the general population can help further elucidate the relation between redox
regulation and psychotic symptoms. Furthermore, genetic risk of psychosis, operationalised as
polygenic risk score of schizophrenia (PRS-SZ), could confound the association between SAF and
psychotic symptoms. Therefore, adjustment for PRS-SZ is warranted when detangling of the
association between above mentioned factors.
Tobacco smoke is a well-known external source of reactive oxygen species. Tobacco smoking is
related with psychotic symptoms in patients with psychosis (Vermeulen et al., 2019) as well as in the
general population (Bhavsar et al., 2018). Although a pathophysiological role of redox dysregulation
and oxidative stress seems plausible, different mechanisms could be dominant. For instance,
overlapping genetic influence to psychosis, smoking behaviour and psychotic experiences could
confound this association (Barkhuizen et al., 2021). Therefore, also the association between tobacco
smoking and self-reported psychotic symptoms needs to be investigated, again taking into account
genetic factors.
Main research questions of this study are to what extent SAF and tobacco smoking are associated
with self-reported psychotic experiences in the general population? We hypothesize that, in the
general population, there are positive associations between SAF and psychotic symptoms and
similarly between tobacco smoking and psychotic symptoms and that these associations are only
partly dependent on PRS-SZ.
Cognitive impairment associated with SSD has been described extensively (Velthorst et al., 2021).
Cognitive impairment in this population might be a direct result of (redox dysregulation-related)
reduced activity of the NMDA-receptor, a hypothesis that is supported by findings of an association
Application form data, biomaterials and linkage
Date 09-01-2023
For questions about this application form, please contact us or check www.lifelines.nl Page 6 of 11
between different biomarkers indicating oxidative stress including plasma AGEs and cognitive
functioning in SDD (Gares-Caballer et al., 2022; Kobori et al., 2021; Wang et al., 2021). In an elderly
population, associations between SAF and other biomarkers indicating redox regulation and
cognitive functioning have been demonstrated cross-sectionally (Chen et al., 2021). However,
described associations in the general population are much weaker compared to in individuals with
SDD (ref). Furthermore, longitudinal associations were attenuated and therefore reverse causation
cannot be excluded. Notably, research has focused mainly on elderly populations and individuals
with diabetes mellitus type II, in whom different pathological mechanisms may be prevalent.
In line with the hypothesis that redox dysregulation is a driving cause of cognitive impairment,
duration and severity of tobacco smoking (an external source of reactive oxygen species) was
associated with the severity of cognitive impairment in the general population (Mons et al., 2013). A
negative association between tobacco smoking and cognitive performance has been demonstrated
in both patients with SDD and controls (Mallet et al., 2022). Smoking cessation (with co-occurrent
decrease in oxidative stress) is associated with improvements in processing speed in patients with
psychosis (Vermeulen et al., 2018).
Differences in cognitive profiles between individuals with clinical and non-clinical psychotic
experiences (Mollon et al., 2016) suggests the need to adjust for genetic factors whilst investigating
the associations between SAF and cognitive functioning symptoms, and similarly between tobacco
smoking and cognitive functioning in the general population. Presence and effects of both genetic
and environmental factors need to be investigated to gain a more thorough understanding of the
underlying process. Adjustment for PRS-SZ could help detangle different plausible mechanisms in the
association between redox regulation and cognition. Our other main research question is to what
extent SAF and tobacco smoking are associated with (change in) cognitive functioning? We
hypothesize that in the general population there are positive associations between SAF and cognitive
functioning and similarly between tobacco smoking and cognitive functioning and that these
associations are not completely explained by PRS-SZ.